期刊文献+

甲状腺激素类似物的研究进展 被引量:4

Progress in the study of thyroid hormone analogues
原文传递
导出
摘要 甲状腺激素类似物是一类新兴药物,通过与甲状腺激素受体选择性结合,在特定组织中发挥拟甲状腺激素作用,尤其在降血脂和能量代谢方面。本文主要介绍了靶向特异的甲状腺激素类似物在临床前动物实验和临床试验的研究进展及应用前景。 Thyroid hormone analogues belong to a novel class of agents, which exert thyromimetic actions by selectively binding to thyroid hormone receptors, especially in the aspects of lipid lowering and calorigenesis. This review focuses on the research and application of selective thyroid hormone analogues in animal experiments and clinical trials.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第7期599-601,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺激素类似物 甲状腺激素受体 血脂异常 Thyroid hormone analogues Thyroid hormone receptor Dyslipidemia
  • 相关文献

参考文献13

  • 1Ladenson PW, Kristensen JD, Ridgway EC, et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med, 2010,362:906-916.
  • 2Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev, 2001,81 : 1097-1142.
  • 3Tancevski I, Wehinger A, Demetz E, et al. The thyromimetic T-0681 protects from atherosclerosis. J Lipid Res, 2009,50:938-944.
  • 4Grover G J, Egan DM, Sleph PG, et al. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3, 5, 3'-triiodo-L-thyronine. Endocrinology, 2004,145 : 1656-1661.
  • 5Erion MD, Cable EE, Ito BR, et all. Targeting thyroid hormone receptor-beta agonists to the liver'educes cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci U S A, 2007, 104 : 15490-15495.
  • 6Ito BR, Zhang BH, Cable EE, et al. Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys. Br J Pharmacol, 2009,156 : 454-465.
  • 7Bryzgalova G, Effendic S, Khan A, et al. Anti-obesity, anti-diabetic. and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. J Steroid Bioehem Mol Biol, 2008,111:262-267.
  • 8Amorim BS, Ueta CB, Freitas BC, et al. A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol, 2009,203 : 291-299.
  • 9Berkenstam A, Kristensen J, Mellstr-m K, et al. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci U S A, 2008,105:663-667.
  • 10Morkin E, Pennoek G, Spooner PH, et al. Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology, 2002,97:218-225.

同被引文献23

  • 1Rastogi MV, LaFranchi SH. Congenital hypothyroidism[J]. Orphanet J Rare Dis, 2010, 10(5): 17.
  • 2Moreno JC, Bikker H, Kempers M J, et al. Inactivating mu- tations in the gene for thyoid oxidase 2 (THOX2) and con- genital hypothyroidism[J]. N Eng J Med, 2002, 347(2): 95- 102.
  • 3Digonnet A, Willemse E, Dekeyser C, etal. Near total thyroid- ectomy is an optimal treatment for graves' disease [J]. Eur Arch Otorhinolaryngol, 2010, 267(6):955-960.
  • 4Alnaqdy A, A1-Maskari M. Levels of cytokines and thyroid au- toantibodies in Omani patients with Graves' disease [J]. Br J Bi- omed Sci, 2007, 64(4):164-167.
  • 5Matthews DC, Syed AA. The role of TSH receptor antibodies in the management of Graves' disease [J]. Eur J Intern Med, 2011, 22(3) :213-216.
  • 6Karoutsou E, Polymeris A. Pathogenesis of Graves' disease fo- cusing on Graves ophthalmopathy [J]. Endocr Regul, 2011, 45 (4) : 209-220.
  • 7Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves disease, and thyroid-associated ophthalmopathy [J]. Thyroid, 2008, 18(9) :953-958.
  • 8Brent GA. Clinical practice. Graves' disease [J]. N Engl J Med, 2008, 358(24):2594-2605.
  • 9阎玉芹,董作亮,董玲,王锋锐,杨学明,金行一,林来祥,孙毅娜,刘嘉玉,陈祖培.正常孕妇早中晚孕期的甲状腺激素参考值范围[J].中华内分泌代谢杂志,2008,24(6):609-612. 被引量:91
  • 10刘靖芳,施秉银.甲状腺激素不敏感综合征分子机制的研究进展[J].中华内分泌代谢杂志,2008,24(6):683-685. 被引量:6

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部